Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0000950170-24-138693

President & CEO sold 132,030 shares at an average $1.00 ($131,650)

From the SEC's structured data for this filing

Trades in this filing

ROBIN HOWARD W · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-12-17 Sale : show line 1 in the form −46,995 $1.01 $47,465 1,195,710 D
2024-12-18 Sale : show line 2 in the form −85,035 $0.99 $84,185 1,110,675 D
Open-market sales · 132,030 sh · avg $1.00 · $131,650
Loading xslF345X05/ownership.xml…